Every material Form 8-K Scotts Miracle-Gro filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On November 21, 2025, Scotts Miracle-Gro entered a Seventh Amended and Restated Credit Agreement providing $2.0 billion of five-year senior secured loans, made up of a $1.5 billion revolving credit facility and a $500 million term loan. The new agreement replaces the Sixth Amended and Restated Credit Agreement dated April 8, 2022, which provided $2.5 billion, and the proceeds may be used to refinance amounts outstanding under the former agreement.
New facilities total $2.0 billion: a $1.5 billion revolver and a $500 million term loan, terminating November 21, 2030.
The prior agreement from April 8, 2022 totaled $2.5 billion, including a $1.0 billion term loan.
Leverage ratio must not exceed 5.00 to 1.00 from the fiscal quarter ending December 27, 2025; restricted payments above a 4.0 to 1.0 leverage ratio are capped at $225 million per fiscal year.
Initial spread is 1.75% on term benchmark and RFR loans and 0.75% on ABR loans until financial statements for the fiscal quarter ending December 27, 2025 are delivered.
Scotts Miracle-Gro said that beginning November 13, 2025, it will use a new form of restricted stock unit award notice for awards to certain employees, including named executive officers, under its Long-Term Incentive Plan. The filing describes an administrative change to equity award paperwork and does not report any change in officers or directors.
Effective date: beginning November 13, 2025
Awards cover certain employees, including named executive officers, under The Scotts Miracle-Gro Company Long-Term Incentive Plan
The new form is filed as Exhibit 10.1, titled Form of Fiscal Year Incentive RSU Award Notice
Scotts Miracle-Gro reported fiscal 2025 results for the year ended September 30, 2025, with net sales down 4% to $3.41 billion from $3.55 billion. GAAP diluted EPS was $2.47, compared with a loss of $0.61 a year earlier, and adjusted EPS rose to $3.74 from $2.29. The company also gave fiscal 2026 guidance calling for adjusted EPS of $4.15 to $4.35, which matters to shareholders as a benchmark for next year's earnings.
Fiscal 2025 net sales were $3,413.1 million, down from $3,552.7 million; fourth-quarter net sales fell 7% to $387.4 million
GAAP diluted EPS was $2.47 for fiscal 2025 versus a loss of $0.61 in fiscal 2024; adjusted diluted EPS was $3.74 versus $2.29
Fourth-quarter net loss narrowed to $151.8 million from $244.0 million a year earlier
Fiscal 2026 guidance includes adjusted EPS of $4.15 to $4.35 and free cash flow of $275 million
Scotts Miracle-Gro amended its uncommitted receivables facility with JPMorgan Chase Bank, extending the purchase termination date from September 1, 2025 to September 1, 2026. The facility lets the company sell up to $750 million of receivables from five specified customers on a weekly basis, and the filing says the company expects to use the proceeds for general corporate purposes.
Purchase termination date extended from September 1, 2025 to September 1, 2026; the amendment is dated August 28, 2025
Facility allows sales of up to $750 million of receivables from five specified customers, on an uncommitted and weekly basis
Standby letters of credit of $75 million support recourse obligations; the company's Performance Undertaking dated October 27, 2023 remains in place
Scotts Miracle-Gro said director John R. Vines retired from its board on July 31, 2025, and the board appointed retired General Austin Scott Miller to fill the vacancy effective August 1, 2025. The filing says Vines' departure was not due to any disagreement with the company, and it describes the change as a routine board refresh with no reported effect on financial results.
John R. Vines notified the company of his retirement on July 31, 2025; he will serve as Board member emeritus in an advisory role.
Austin Scott Miller was appointed as a Class II director effective August 1, 2025, with a term expiring at the 2027 annual meeting.
Miller joins the Nominating and Governance Committee and the Innovation & Technology Committee and was determined to be independent under NYSE and SEC rules.
Miller's 2025 pro-rated director pay includes $47,917 in cash retainer payments and restricted stock units with a grant date value of $87,500.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Scotts Miracle-Gro filing is on SEC EDGAR ↗. 8-K briefs of other companies →